Moderna Begins Testing Its Covid-19 Vaccine on Children

Moderna is beginning a research study to test the Covid-19 vaccine on children for the first time, according to NPR. The drug company is focusing on children as young as six-month-old infants up to younger than 12 years old.

Each of the children will receive either the Covid-19 vaccine or a placebo made of saline. The National Institute of Allergy and Infectious Diseases is collaborating with Moderna on the study.

“There’s a huge demand to find out about vaccinating kids and what it does,” Dr. David Wohl, the medical director of the vaccine clinic at the University of North Carolina, who is not participating in the study, said, according to The New York Times.

The current Covid-19 vaccine that is being administered is only for people 18 years and older. Moderna also plans to monitor adolescents in another research study.

The company revealed last December that it was planning to study the vaccine’s impact on adolescents. As a result, Moderna has now successfully enrolled 3,000 people in the research study.

In addition, Pfizer is also beginning to test its Covid-19 vaccine on young children. The company is concentrating on 2,259 kids who are 12 to 15 years old. Pfizer projects it will make the data available in the first half of this year.

Johnson & Johnson also plans to test its vaccine, which requires one dose compared to two doses for Pfizer and Moderna, on infants and young children. However, the company will do so only after initially testing it on older children.